CIMAC Data definition

CIMAC Data means CIMAC-generated data in the performance of the Research Project, including, but not limited to, assay output and data on assay validation and performance using Biospecimens.
CIMAC Data means CIMAC-generated data including, but not limited to, assay output and data on assay validation and performance using clinical trial samples. The CIMAC Data will be jointly owned by the Provider and the CIMAC that generated the data from the Human Material. The CIMAC will own the data they generate that do not relate to a Research Project (for example, improvements to assays that are not directly related to specific Human Material).

Examples of CIMAC Data in a sentence

  • Provider will have use of the Results and the CIMAC Data generated from the Human Material without accounting to the other Party(ies) after the expiration of the Exclusivity Period and in compliance with the Sections on Publication and Authorship of this Agreement.

  • Each Party agrees that a Party providing Human Material, CIMAC Data, or Results will not be held liable for any loss, harm, illness, or other damage or injury (each a “Liability”) arising from another Party’s receipt, handling, use, or disposal of the Human Material, CIMAC Data, or Results except to the extent such Liability arises from or is due to the gross negligence or willful misconduct of the providing Party.

  • No Party makes any warranties, express or implied, as to any matter whatsoever, including without limitation, as to the quality, fitness for any particular purpose, merchantability, or noninfringement with regard to any Human Material, Cross-Trial Analysis, CIMAC Data, or Results.

  • Each Recipient CIMAC will have full rights to use the CIMAC Data that it generates that is not specifically related to the Research Project or use of the Human Material (for example, improvements to assays that are not directly related to specific Human Material).

  • In all oral presentations or written publications arising from the use of the Human Material from PACT-Funded Trials, PACT-Funded CIMAC Data, or PACT Results, the PACT team (including NCI and industry sponsors), CIMAC-CIDC, PACT Collaborator, and Provider will be acknowledged unless requested otherwise.Acknowledgement language for the PACT team will be provided to each Supplemental Biomarker Analysis Team.

  • All publications based on PACT-Funded CIMAC Data should recognize this collaboration, through authorship, consistent with general authorship guidelines for collaborative work and mutually agreed upon by all parties.

  • Recipients will at all times retain rights to use Results and the CIMAC Data for all purposes in accordance with this Agreement.

  • For secondary abstracts/manuscripts that report primarily PACT-Funded CIMAC Data or PACT Results, it may be appropriate that CIMAC-CIDC lead investigators/statisticians have the lead or co-lead authorship roles.

  • All inventions created using data from PACT-Funded CIMAC Data or PACT Results will adhere to the PACT Intellectual Property Policy ratified within the PACT Research Plan and detailed below.

  • Clinical Data, or Results and CIMAC Data pertaining to Clinical Data in the CIDC will not be published by CIMAC-CIDC investigators without the permission of the NCI and the Provider.

Related to CIMAC Data

  • DXC Data means the content, information and data pertaining to DXC and/or DXC Customers that is submitted to or accessed by Supplier pursuant to this Agreement. DXC Data may include, but is not limited to the following, each of which is defined more fully herein, DXC Sensitive Information, Confidential Information, Personal Information, and Protected Health Information (PHI).

  • biometric data means personal data resulting from specific technical processing relating to the physical, physiological or behavioural characteristics of a natural person, which allow or confirm the unique identification of that natural person, such as facial images or dactyloscopic data;

  • traffic data means any data processed for the purpose of the conveyance of a communication on an electronic communications network or for the billing thereof;

  • genetic data means personal data relating to the inherited or acquired genetic characteristics of a natural person which give unique information about the physiology or the health of that natural person and which result, in particular, from an analysis of a biological sample from the natural person in question;

  • Public data means the objective, factual data on which policy decisions are based and on which public services are assessed, or which is collected or generated in the course of public service delivery.

  • Non-Public Data means Customer Data, other than Personal Data, that is not subject to distribution to the public as public information. It is deemed to be sensitive and confidential by Customer because it contains information that is exempt by statute, ordinance or administrative rule from access by the general public as public information. Non-Public Data includes any data deemed confidential pursuant to the Contract, otherwise identified by Customer as Non-Public Data, or that a reasonable person would deem confidential.

  • GLO Data means any data or information owned by the GLO, including PII or SPI as defined below, that Provider creates, obtains, accesses (via records, systems, or otherwise), receives (from the GLO or on behalf of the GLO), or uses in the performance of the Contract or any documents related thereto.

  • UNICEF Data means any and all information or data in digital form or processed or held in digital form that

  • Electronic Data means information, facts or programs stored as or on, created or used on, or transmitted to or from computer software, including systems and applications software, hard or floppy disks, CD-ROMS, tapes, drives, cells, data processing devices or any other media which are used with electronically controlled equipment.

  • Electronic Data Interchange (EDI means technology that provides transaction related details, including invoice number(s), pay dates, and other identifying information as appropriate for each transaction.

  • Electronic Data Room means the electronic data room established by or on behalf of Seller with respect to the Acquired Companies, as the same exists as of the date of this Agreement.

  • Electronic Data Interchange or “EDI technology” means the computer-to-computer exchange of business transactions in a standardized, structured electronic format.

  • Regulatory Materials means regulatory applications, submissions, notifications, registrations, Marketing Authorizations or other written materials, correspondence, submissions made to or with a Regulatory Authority that are necessary or reasonably desirable in order to Develop, Manufacture or Commercialize the Licensed Products in the Field in a particular country.

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Program Know-How means Information, whether or not patentable, that is conceived, generated, discovered, or created by one or both Parties or their Affiliates, or by any Third Party working on behalf of one or both Parties or their Affiliates, at any time during the Research Program Term as a direct result of the performance of the activities under the Research Program. Program Know-How shall include Results and Program Inventions and shall exclude Program Patents.

  • Regulatory Documentation means, with respect to the Compounds, all submissions to Regulatory Authorities in connection with the development of such Compounds, including all INDs and amendments thereto, NDAs and amendments thereto, drug master files, correspondence with regulatory agencies, periodic safety update reports, adverse event files, complaint files, inspection reports and manufacturing records, in each case together with all supporting documents (including documents that include Clinical Data).

  • Third Party Data has the meaning set forth in Section 9.3(a).

  • Customer Materials any materials, data, information, software, equipment or other resources owned by or licensed to You and made available to Us pursuant to facilitating Your use of the Services, including Customer Data.

  • Postconsumer material means a material or finished product that has served its intended use and has been discarded for disposal or recovery, having completed its life as a consumer item. Postconsumer material is a part of the broader category of “recovered material.”

  • Regulatory Filings means all applications, filings, dossiers and the like submitted to a Regulatory Authority in a particular jurisdiction for the purpose of obtaining Regulatory Approval of a Licensed Product from that regulatory authority with respect to such jurisdiction. Regulatory Filings shall include, but not be limited to, all INDs and Drug Approval Applications for Licensed Product.

  • Portfolio Data means the Key Terms in relation to all outstanding Trades between you and us in a form and standard that is capable of being reconciled. The information comprising the Portfolio Data for Portfolio Data Delivery Date will be prepared as at the close of business New York time on the immediately preceding Business Day.

  • Supplier Materials has the meaning given in clause 8.1(h).

  • Post-consumer material means a material or finished product that has served its intended use and has been discarded for disposal or recovery, having completed its life as a consumer item. Post consumer material is a part of the broader category of "recycled content."

  • Program Information has the meaning set forth in Section 14.8.

  • Licensed Data means the data licensed by the LME to the Licensee set out in the Order Form and further defined in Schedule 1 (Licensed Data);

  • Regulatory Filing means any filing with any Governmental Authority with respect to the research, development, manufacture, distribution, pricing, reimbursement, marketing or sale of a Product.